Pesquisa sobre: TRYPSIN INHIBITOR, KAZAL PANCREATIC 
Descritores Encontrados: 1
Mostrando: 1 .. 1  

 1 / 1 DeCS     
Descritor Inglês:   Trypsin Inhibitor, Kazal Pancreatic 
Descritor Espanhol:   Inhibidor de Tripsina Pancreática de Kazal 
Descritor Português:   Inibidor da Tripsina Pancreática de Kazal 
Sinônimos Inglês:   Acidic Pancreatic Trypsin Inhibitor
Inhibitor, Tumor Associated Trypsin
Inhibitor, Tumor-Associated Trypsin
Kazal Pancreatic Trypsin Inhibitor
Pancreatic Secretory Trypsin Inhibitor
Pancreatic Secretory Trypsin Inhibitor, Kazal
Pancreatic Trypsin Secretory Inhibitor, Kazal
SPINK1
Serine Peptidase Inhibitor, Kazal Type 1
Serine Peptidase Inhibitor, Kazal-Type 1
Serine Protease Inhibitor Kazal Type 1
Serine Protease Inhibitor Kazal-Type 1
Trypsin Inhibitor Kazal Pancreatic
Trypsin Inhibitor, Pancreatic Secretory
Trypsin Inhibitor, Tumor Associated
Trypsin Inhibitor, Tumor-Associated
Tumor Associated Trypsin Inhibitor
Tumor-Associated Trypsin Inhibitor  
Categoria:   D12.644.822.750.500
D12.776.124.050.850
D12.776.645.688.500
Definição Inglês:   A secreted KAZAL MOTIF-containing serine peptidase inhibitor that inhibits TRYPSIN. It is a protein composed of 56 amino acid residues and is different in amino acid composition and physiological activity from the Kunitz bovine pancreatic trypsin inhibitor (APROTININ). It protects against the trypsin-mediated premature activation of ENZYME PRECURSORS in the PANCREAS. Mutations in the SPINK1 gene are associated with CHRONIC PANCREATITIS. 
Relacionados Inglês:   Kazal Motifs
 
Nota Histórica Inglês:   91(75); was see under TRYPSIN INHIBITORS 1975-90 
Qualificadores Permitidos Inglês:  
AD administration & dosage AE adverse effects
AG agonists AN analysis
BI biosynthesis BL blood
CF cerebrospinal fluid CS chemical synthesis
CH chemistry CL classification
DF deficiency DE drug effects
EC economics GE genetics
HI history IM immunology
IP isolation & purification ME metabolism
PK pharmacokinetics PD pharmacology
PH physiology PO poisoning
RE radiation effects ST standards
SD supply & distribution TU therapeutic use
TO toxicity UL ultrastructure
UR urine  
Número do Registro:   27874 
Identificador Único:   D014359 

Ocorrência na BVS:
 
LILACS    
MEDLINE    
IBECS    

Similar:

 
DeCS